INTI — Inhibitor Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Inhibitor Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.804	0.075	0.031	12	8.84
Prepaid Expenses
Total Current Assets	0.846	0.107	0.059	12	8.95
Other Long Term Assets
Total Assets	0.9	0.132	0.059	12	8.95
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.431	0.425	0.68	0.679	0.665
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.43	3.49	3.68	3.68	3.67
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-2.53	-3.36	-3.62	8.3	5.28
Total Liabilities & Shareholders' Equity	0.9	0.132	0.059	12	8.95
Total Common Shares Outstanding
Total Preferred Shares Outstanding